MDA-kb2 Cells
CAD$593.40*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MDA-kb2 cell line is a human breast cancer cell line derived from an adult patient. These cells are estrogen receptor (ER) negative and androgen receptor (AR) positive, making them valuable for studies involving androgen signaling pathways and their implications in breast cancer. The MDA-kb2 cell line was derived from the breast cancer cell line, MDA-MB-453, by stable transfection with a mouse mammary tumor virus (MMTV)-Luc-neo reporter gene construct. This genetic modification allows for the use of MDA-kb2 cells in bioassays for androgenic and anti-androgenic activities, where they are often utilized in-Luc reporter assays due to their stable transfection with a-Luc reporter gene under the control of an androgen-responsive promoter. Due to their specific receptor profile, MDA-kb2 cells provide a crucial model for investigating the role of androgens in breast cancer progression and for testing the efficacy of potential therapeutic agents targeting AR pathways. These cells are cultured in Leibovitz's L-15 medium supplemented with 10% fetal bovine serum, under conditions that do not require CO2 supplementation, which is an atypical characteristic compared to many other cell lines. The unique properties of MDA-kb2 cells make them an indispensable tool in both basic research and pharmaceutical development, particularly in understanding hormone receptor interactions in breast cancer. |
|---|---|
| Organism | Human |
| Tissue | Breast, Mammary gland |
| Disease | Breast adenocarcinoma |
| Metastatic site | Pericardial effusion |
| Synonyms | MDA-Kb2 |
Characteristics
| Age | 48 years |
|---|---|
| Gender | Female |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | MDA-kb2 (Cytion catalog number 305108) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_6421 |
| GMO Status | GMO-S1: This human breast cancer reporter cell line (MDA-kb2) contains a firefly-Luc construct delivered via lentiviral vector under a hormone-responsive promoter, enabling glucocorticoid and androgen receptor assays. The insert is stably integrated. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
| Protein expression | The cell line expresses firefly-Luc under control of the MMTV promoter that contains response elements for both glucocorticoid receptors (GR) and androgen receptors (AR) |
|---|
Handling
| Culture Medium | Leibovitz's L-15, w: 2.0 mM L-Glutamine, 0.55 g/L NaHCO3 (We do not supply this product; please consider other suppliers. Please let us know if you need further assistance) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|